A.forall announced through its U.S. subsidiary, Milla Pharmaceuticals Inc., that it has received Abbreviated New Drug Application (ANDA) approval by the U.S. Food and Drug Administration (FDA) for a ...

Most economists were expecting mortgage rates to fall over the course of the coming year. But rates have risen steadily over the last month, inching back up to 7% — and they’re expected to ...

Your home needs an urgent repair (a plumbing issue, for instance) or is on the verge of needing one (sinking foundation) and ...

Ongoing strength in the U.S. economy drove mortgage rates up over 7% for the first time in eight months, casting doubt over a recovery in the housing sector. The 30-year mortgage rate inched up to ...

FORT LAUDERDALE, FL / ACCESS Newswire / January 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a ...

Use This is Money and L&Cs best mortgage rates calculator to show deals matching your home value, mortgage size, term and fixed rate needs. If you’re ready to find your next mortgage ...

WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug ...

The rate on the 30-year mortgage, the most popular home loan in the United States, jumped to 7.04 percent this week, up from 6.93 percent the previous week. Mortgage rates tend to track the yield ...

Calculate monthly payments for different loan scenarios with our Mortgage Calculator. The rates we publish won’t compare directly with teaser rates you see advertised online since those rates ...

The average contract rate on a 30-year fixed-rate mortgage rose 10 basis points in the week ended Jan. 10, the Mortgage Bankers Association said on Wednesday. It was the fifth straight weekly rise ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

The FTC’s findings—which analyzed 51 specialty generic drugs from 2017 to 2022—showed these pharmacy benefit managers’ (PBMs') affiliated pharmacies spun up $7.3 billion in excess revenue ...